-
2
-
-
0032030891
-
Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia
-
Lawler J, Sunday M, Thibert V et al.: Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J. Clin. Invest. 101(5), 982-992 (1998).
-
(1998)
J. Clin. Invest.
, vol.101
, Issue.5
, pp. 982-992
-
-
Lawler, J.1
Sunday, M.2
Thibert, V.3
-
3
-
-
4444353257
-
Tumor progression: The effects of thrombospondin-1 and -2
-
Lawler J, Detmar M: Tumor progression: the effects of thrombospondin-1 and -2. Int. J. Biochem. Cell Biol. 36(6), 1038-1045 (2004).
-
(2004)
Int. J. Biochem. Cell Biol.
, vol.36
, Issue.6
, pp. 1038-1045
-
-
Lawler, J.1
Detmar, M.2
-
4
-
-
60749091126
-
Regulation of nitric oxide signalling by thrombospondin 1: Implications for anti-angiogenic therapies
-
Isenberg JS, Martin-Manso G, Maxhimer JB et al.: Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies. Nat. Rev. Cancer 9(3), 182-194 (2009).
-
(2009)
Nat. Rev. Cancer
, vol.9
, Issue.3
, pp. 182-194
-
-
Isenberg, J.S.1
Martin-Manso, G.2
Maxhimer, J.B.3
-
5
-
-
0036085651
-
Increased plasma thrombospondin-1 (TSP-1) levels are associated with the TNF α-308A allele in children with juvenile dermatomyositis
-
Lutz J, Huwiler KG, Fedczyna T et al.: Increased plasma thrombospondin-1 (TSP-1) levels are associated with the TNF α-308A allele in children with juvenile dermatomyositis. Clin. Immunol. 103(3 Pt 1), 260-263 (2002).
-
(2002)
Clin. Immunol.
, vol.103
, Issue.3 PART 1
, pp. 260-263
-
-
Lutz, J.1
Huwiler, K.G.2
Fedczyna, T.3
-
6
-
-
79952148387
-
Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties
-
Smadja DM, d'Audigier C, Bieche I et al.: Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties. Arterioscler. Thromb. Vasc. Biol. 31, 551-559 (2011).
-
(2011)
Arterioscler. Thromb. Vasc. Biol.
, vol.31
, pp. 551-559
-
-
Smadja, D.M.1
D'Audigier, C.2
Bieche, I.3
-
9
-
-
38349132563
-
Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling
-
Isenberg JS, Romeo MJ, Yu C et al.: Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling. Blood 111(2), 613-623 (2008).
-
(2008)
Blood
, vol.111
, Issue.2
, pp. 613-623
-
-
Isenberg, J.S.1
Romeo, M.J.2
Yu, C.3
-
10
-
-
45849102323
-
Cyclic stretch affects pulmonary endothelial cell control of pulmonary smooth muscle cell growth
-
Ochoa CD, Baker H, Hasak S et al.: Cyclic stretch affects pulmonary endothelial cell control of pulmonary smooth muscle cell growth. Am. J. Respir. Cell Mol. Biol. 39(1), 105-112 (2008).
-
(2008)
Am. J. Respir. Cell Mol. Biol.
, vol.39
, Issue.1
, pp. 105-112
-
-
Ochoa, C.D.1
Baker, H.2
Hasak, S.3
-
11
-
-
33847372168
-
Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation
-
Isenberg JS, Hyodo F, Matsumoto K et al.: Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation. Blood 109(5), 1945-1952 (2007).
-
(2007)
Blood
, vol.109
, Issue.5
, pp. 1945-1952
-
-
Isenberg, J.S.1
Hyodo, F.2
Matsumoto, K.3
-
12
-
-
60749126714
-
Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress
-
Isenberg JS, Qin Y, Maxhimer JB et al.: Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress. Matrix Biol. 28(2), 110-119 (2009).
-
(2009)
Matrix Biol.
, vol.28
, Issue.2
, pp. 110-119
-
-
Isenberg, J.S.1
Qin, Y.2
Maxhimer, J.B.3
-
13
-
-
33748747969
-
CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1
-
Isenberg JS, Ridnour LA, Dimitry J et al.: CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J. Biol. Chem. 281(36), 26069-26080 (2006).
-
(2006)
J. Biol. Chem.
, vol.281
, Issue.36
, pp. 26069-26080
-
-
Isenberg, J.S.1
Ridnour, L.A.2
Dimitry, J.3
-
14
-
-
78149288324
-
Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation
-
Bauer EM, Qin Y, Miller TW et al.: Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation. Cardiovasc. Res. 88(3), 471-481 (2010).
-
(2010)
Cardiovasc. Res.
, vol.88
, Issue.3
, pp. 471-481
-
-
Bauer, E.M.1
Qin, Y.2
Miller, T.W.3
-
15
-
-
77952861606
-
Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension
-
Ochoa CD, Yu L, Al-Ansari E et al.: Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension. J. Cardiothorac. Surg. 5, 32 (2010).
-
(2010)
J. Cardiothorac. Surg.
, vol.5
, pp. 32
-
-
Ochoa, C.D.1
Yu, L.2
Al-Ansari, E.3
-
16
-
-
26444539058
-
Expression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertension
-
Kwapiszewska G, Wilhelm J, Wolff S et al.: Expression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertension. Respir. Res. 6, 109 (2005).
-
(2005)
Respir. Res.
, vol.6
, pp. 109
-
-
Kwapiszewska, G.1
Wilhelm, J.2
Wolff, S.3
-
17
-
-
79953738183
-
Thrombospondin-1 Promotes Hypoxia-Induced Pulmonary Hypertension
-
Absracts A6338
-
Bauer E, Champion H, Isenberg J et al.: Thrombospondin-1 Promotes Hypoxia-Induced Pulmonary Hypertension. Am. J. Respir. Crit. Care Med. 181 (2010) (Absracts A6338).
-
(2010)
Am. J. Respir. Crit. Care Med.
, vol.181
-
-
Bauer, E.1
Champion, H.2
Isenberg, J.3
-
18
-
-
79953762083
-
-
Accessed 30 December 2010
-
Vasculox Inc.: Vasculox News and Updates www.vasculox.com/news-updates (Accessed 30 December 2010)
-
Vasculox News and Updates
-
-
-
19
-
-
79953749618
-
Development of a humanized Anti-CD47 antibody for treatment of tissue ischemia
-
Accessed 30 December 2010
-
Frazier WA: Development of a humanized Anti-CD47 antibody for treatment of tissue ischemia. National Institutes of Health Research Portfolio Online Reporting Tools (RePORT) http://projectreporter.nih.gov/project-info- description.cfm?aid=7669899&icde=6533299 (Accessed 30 December 2010)
-
National Institutes of Health Research Portfolio Online Reporting Tools (RePORT)
-
-
Frazier, W.A.1
|